ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Natco Pharma soars after Mylan settles Ozempic patent dispute
Natco Pharma rose 3.39% to Rs 1400.60 after the company announced a settlement in the U.S. patent litigation for generic Ozempic.
Announcement as on 07 October 2024

Natco Pharma stock rises 3% after subsidiary invests mn in biotech firm
Natco Pharma share price rose after the company on Wednesday announced that its wholly owned Canadian subsidiary, NATCO Pharma Inc, has made an investment of million in eGenesis
Announcement as on 04 September 2024

Natco Pharma acquires 40 million shares in eGenesis Inc
Natco Pharma's Canadian subsidiary has acquired 40 million shares in eGenesis Inc. for USD 8 million. eGenesis is a biotechnology company developing human-compatible organs for transplant through xenotransplantation. This investment aims to support eGenesi
Announcement as on 04 September 2024

Technical Breakout Stocks: PB Fintech up 90% in a year; Ajanta Pharma, Natco Pharma hit record highs
Indian markets rebounded on Wednesday after three days of declines, with the Sensex up nearly 900 points and Nifty50 rising over 300 points. Key sectors showing gains included PSU, energy, and metals.
Announcement as on 07 August 2024

USFDA pulls up Natco Pharma for several violations at Telangana plant
Natco Pharma failed to maintain cleanliness, sterilise equipment and utensils at appropriate intervals at its Telangana-based plant, as per the US health regulator. In the warning letter to the company, US Food and Drug Administration said its investigator
Announcement as on 21 April 2024

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 788.68
  • 12Day Average: 810.28
  • 20Day Average: 814.97
  • 50Day Average: 851.34
  • 100Day Average: 901.44
  • 150Day Average: 955.28
  • 200Day Average: 936.22

524816 Indicators & signals

Indicator MACD (12,26,9)

804.54, 820.91, -15.23
Indicator MACD is in negative zone

Indicator ADX (14)

16.52, 15.97, 22.3
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 44
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
19 Mon Oct 2026 800.75 778.75 to 809.75 1.97% 2.13 times
16 Fri Oct 2026 785.25 781.00 to 788.50 0.06% 0.3 times
15 Thu Oct 2026 784.80 780.00 to 787.75 0.23% 0.72 times
14 Wed Oct 2026 783.00 781.00 to 794.85 -0.84% 1.06 times
13 Tue Oct 2026 789.60 787.50 to 803.55 -1.32% 0.41 times
12 Mon Oct 2026 800.20 789.10 to 804.15 -2.85% 1.31 times
06 Tue Oct 2026 823.70 815.55 to 826.00 0.19% 0.89 times
05 Mon Oct 2026 822.15 801.35 to 827.65 0.05% 1.25 times
01 Thu Oct 2026 821.75 803.30 to 826.75 -2.63% 0.91 times
29 Tue Sep 2026 843.95 827.90 to 851.65 1.91% 0.98 times
28 Mon Sep 2026 828.10 824.00 to 856.30 -1.42% 2.18 times
25 Fri Sep 2026 840.05 835.00 to 850.20 -0.21% 0.63 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top